AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
CALM
ACCE-researched

Cal-Maine Foods Inc. Common Stock (CALM) fair value

Consumer Defensive · Farm Products · NASDAQ · United States
$62.60-1.93%
Market cap $2.9BNext earnings 2026-09-30Updated Oct 19, 2026
Our verdict
Trades 18% below our fair value
Price
$62.60
Model fair valueConfidence: good
$75.91
Model range
$19.44 to $139
Fair value $75.91
Price $62.60
3 models fit Cal-Maine Foods Inc. Common Stock and they disagree: 1 of 3 land within 15% of the average.
Two or more of our models back this value.
Discount(i)Bronze47
Valued as a mature, profitable company: Discounted cash flow, EV/EBITDA comparison, Graham number, and Dividend discount.
ACCE opinionCal-Maine Foods Inc. Common Stock (CALM)
Fair value (3 models)
$75.91
ACCE price target
$57.90
Rating
Undervalued
Horizon
12 months
Fair value published on 19 Oct 2026, 18:04 CEST; previously $82.96 since 11 Oct 2026, 00:00 CEST.
ACCE price target published on 18 Oct 2026, 00:00 CEST; previously $62.00 since 17 May 2026, 00:00 CEST.
Rating published on 19 Oct 2026, 18:04 CEST.
Price used: $62.60 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, Graham number, and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
17.5% below
+21.3% to fair value
ACCE score
29
out of 100
Analysts
0% buy
4 covering
P/E
50.9x
forward 61.7x
1-year return
-29.9%
Dividend yield
3.84%

Cal-Maine Foods Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Cal-Maine Foods is the largest U.S. producer of shell eggs, selling branded and private-label cartons to retail and foodservice customers, with a flock large enough to make it a price-setter in a commodity market. Its moat is scale and cost position rather than brand, and that matters most when egg prices are high and rivals cannot restock quickly. The current picture is a cyclical trough: revenue is down 41.5% year on year, gross margin is 14.3%, and operating margin is negative at -15.1%, so trailing earnings look expensive at 51.7 times while the forward multiple of 19.8 implies the market expects a recovery. The thesis depends on flock rebuilding and egg prices normalising, which would restore operating leverage quickly given the fixed-cost structure. The score of 29/100 and absence from any index mean the name has little institutional support and the debate is still open. It merits a deeper look only if you have a view on the egg cycle and can underwrite the timing of that recovery.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • severe
    Negative free cash flow
    FCF of -$175.8M indicates the business is burning cash. Combined with -41.5% revenue decline, sustainability is in question.
  • high
    Revenue and earnings collapse
    Revenue down 41.5% YoY, earnings down 89.8% YoY. Operating margin deeply negative at -15.1%. Business under severe stress.
  • high
    ACCE score deterioration
    Score fell 36 points in 90 days (55 to 19).
  • high
    Valuation disconnect
    Forward P/E 63.4 on a business with negative operating margin and collapsing earnings. Pricing assumes recovery not yet evident in results.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-10-10 · prices to Oct 23, 2026
Why it could do well
  • Consensus valuations across all 4 models suggest 28.9% upside to fair value of $82.96.
  • Management repurchased 2.3% of shares last year, reducing dilution and supporting per-share metrics.
  • The 3.8% dividend yield provides income while the stock trades 6.2% below analyst mean target.
Why it could disappoint
  • Revenue collapsed 41.5% year over year with negative free cash flow of $176M in trailing twelve months.
  • Trailing P/E of 52.3x and forward P/E of 63.4x are extreme for a business with 2.3% net margins.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where CALM's valuation models land
Price
$62.60
Model fair value
$75.91
Model range
$19.44 to $139
Fair value $75.91
Price $62.60
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
EV/EBITDA comparison
Graham number
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish0% buy · 4 covering analysts
● Strong buy 0● Buy 0● Hold 4● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-1.6%
1 month
-12.7%
3 months
-30.7%
6 months
-17.9%
YTD
-21.3%
1 year
-29.9%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
19 Oct 2026, 18:04 CESTRatingUndervaluedfirst publication$63.65
19 Oct 2026, 18:04 CESTFair value$75.91$82.96$63.65
18 Oct 2026, 00:00 CESTACCE price target$57.90$62.00$63.65
11 Oct 2026, 00:00 CESTFair value$82.96$85.41$64.35
10 Oct 2026, 00:00 CESTFair value$85.41$111$64.83
6 Oct 2026, 00:00 CESTFair value$111$98.65$66.67
2 Oct 2026, 00:00 CESTFair value$98.65$101$65.98
1 Oct 2026, 00:00 CESTFair value$101$98.81$68.55
28 Sept 2026, 00:00 CESTFair value$98.81$101$67.43
26 Sept 2026, 00:00 CESTFair value$101$104$68.48

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full CALM page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value70Quality23Momentum17Total29
Valuation
Trailing P/E
50.9x
Forward P/E
61.7x
PEG
no data
P/B
1.30x
EV / Revenue
0.9x
Book value/sh
$54.77
Enterprise value
$2.4B
Profitability
ROE
2.4%
FCF yield
11.13%
ROIC
9.9%
Health and risk
Debt / equity
no data
Dividend yield
3.84%
Beta
0.23

Price

-30.5% · 1Y

Ask anything about CALM

Answered from Cal-Maine Foods Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 0% of peers
low 4.6x50.9xhigh 50.9x
ROEbetter than 0% of peers
low 2%2%high 132%
Div yieldbetter than 67% of peers
low 0.3%3.8%high 16.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
CALM Cal-Maine Foods Inc. Common Stock$62.60$7618% below50.9x2.4%2329
LOUP.PA L.D.C. S.A.€104.60€16838% below11.3x13.3%6166
AGRO Adecoagro S.A. Common Shares$9.83$1947% below25.9x3.7%5065
DOLE Dole plc Ordinary Shares$13.52$2340% below17.8x6.9%3051
AEP.L AEP Plantations Plc£1.63£234% below8.8x14.8%7567
MOWI.OL Mowikr 215.80kr 2122% above15.6x15.5%5963
MOLA.BA Molinos Agro SAARS 20900.00--4.6x132.1%4953

Sector report card

Where CALM ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Sep 9, 2026
    Cal-Maine Foods Schedules First Quarter Fiscal 2027 Earnings Release, Conference Call and Webcast
  • GlobeNewswire•Aug 31, 2026
    Cal-Maine Foods to Participate in Barclays Global Consumer Conference
  • GlobeNewswire•Aug 31, 2026
    Cal-Maine Foods Releases Fiscal Year 2025 Impact Report
2 more press releases · full archive on Investor+.INVESTOR
31 filings of 40
October 2026
Oct 2
8-KCurrent reportPeriod 2026-10-02
View on SEC →
September 2026
Sep 30
8-KCurrent reportPeriod 2026-09-30
View on SEC →
Sep 30
10-QQuarterly reportPeriod 2026-08-29
View on SEC →
28 more filings + AI summaries on Investor+.INVESTOR